VRIO Analysis of Akari Therapeutics Plc
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Akari Therapeutics Plc will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Akari Therapeutics Plc VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Akari Therapeutics Plc VRIO Analysis shows that the financial resources of Akari Therapeutics Plc are highly valuable as these help in investing into external opportunities that arise. These also help Akari Therapeutics Plc in combating external threats.
- According to the VRIO Analysis of Akari Therapeutics Plc, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Akari Therapeutics Plc VRIO Analysis shows that Akari Therapeutics Plc's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Akari Therapeutics Plc's products.
- According to the VRIO Analysis of Akari Therapeutics Plc, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Akari Therapeutics Plc. These patents also provide Akari Therapeutics Plc with licensing revenue when it licenses these patents out to other manufacturers.
- The Akari Therapeutics Plc VRIO Analysis shows that Akari Therapeutics Plc’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Akari Therapeutics Plc. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Akari Therapeutics Plc, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Akari Therapeutics Plc VRIO Analysis shows that the research and development at Akari Therapeutics Plc is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Akari Therapeutics Plc. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Akari Therapeutics Plc are found to be rare according to the VRIO Analysis of Akari Therapeutics Plc. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Akari Therapeutics Plc VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Akari Therapeutics Plc and inhibit competitive advantage. This means that the local food products result in competitive parity for Akari Therapeutics Plc. As this resource is valuable, Akari Therapeutics Plc can still make use of this resource.
- The employees of Akari Therapeutics Plc are a rare resource as identified by the VRIO Analysis of Akari Therapeutics Plc. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Akari Therapeutics Plc are a rare resource as identified by the Akari Therapeutics Plc VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Akari Therapeutics Plc to use them without interference from the competition.
- The distribution network of Akari Therapeutics Plc is a rare resource as identified by the VRIO Analysis of Akari Therapeutics Plc. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Akari Therapeutics Plc. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Akari Therapeutics Plc are costly to imitate as identified by the Akari Therapeutics Plc VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Akari Therapeutics Plc. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Akari Therapeutics Plc provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Akari Therapeutics Plc are also not costly to imitate as identified by the Akari Therapeutics Plc VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Akari Therapeutics Plc by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Akari Therapeutics Plc a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Akari Therapeutics Plc are very difficult to imitate as identified by the VRIO Analysis of Akari Therapeutics Plc. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Akari Therapeutics Plc is also very costly to imitate by competition as identified by the Akari Therapeutics Plc VRIO Analysis. This has been developed over the years gradually by Akari Therapeutics Plc. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Akari Therapeutics Plc are organised to capture value as identified by the VRIO Analysis of Akari Therapeutics Plc. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Akari Therapeutics Plc.
- The Patents of Akari Therapeutics Plc are not well organised as identified by the Akari Therapeutics Plc VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Akari Therapeutics Plc starts selling patented products before the patents expire.
- The distribution network of Akari Therapeutics Plc is organised as identified by the VRIO Analysis of Akari Therapeutics Plc. Akari Therapeutics Plc uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Akari Therapeutics Plc.
From the VRIO Analysis of Akari Therapeutics Plc, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Akari Therapeutics Plc is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Emily Edward
4.0
Thank you for the timely reply. Applaud to you writer for clearing my concepts about the Decision Making and Cost-Benefit Analysis because it's a very lengthy topic!
Kun Cong
5.0
To say thanks and recommend this service to others is a slight job that I can do in the reward for this service. Paper was promptly and perfectly composed!
Regina Zajzon
5.0
I ordered them for Economics and my friend for Statistics. We are lucky that we got discounts from them and we are happy with our work too.
Finn Gabriel
5.0
Used this service a couple of times during college life and all time got good grades. Thank you!
Next Articles
- Albireo Pharma, Inc. Vrio Analysis
- Alder Biopharmaceuticals, Inc. Vrio Analysis
- Aldeyra Therapeutics, Inc. Vrio Analysis
- Align Technology, Inc. Vrio Analysis
- Alimera Sciences, Inc. Vrio Analysis
- Alkermes Plc Vrio Analysis
- Alnylam Pharmaceuticals, Inc. Vrio Analysis
- Analogic Corporation Vrio Analysis
- Alliqua BioMedical, Inc. Vrio Analysis
- Alere Inc. Vrio Analysis
Previous Articles
- Akorn, Inc. Vrio Analysis
- Akers Biosciences, Inc. Vrio Analysis
- Akebia Therapeutics, Inc. Vrio Analysis
- Achaogen, Inc. Vrio Analysis
- Alliance Healthcare Services, Inc. Vrio Analysis
- Aimmune Therapeutics, Inc. Vrio Analysis
- Allied Healthcare Products, Inc. Vrio Analysis
- Applied Genetic Technologies Corporation Vrio Analysis
- Agile Therapeutics, Inc. Vrio Analysis
- Allergan Plc Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!